Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters appied:
Tag
close icon
Sort by
IMPACT OF ROTAVIRUS VACCINATION ON CHILDHOOD HOSPITALIZATIONS FOR SEIZURES: HETEROLOGOUS OR UNFORESEEN DIRECT VACCINE EFFECTS?
Salas, A; Pardo-Seco, J; Cebey-Lopez, M; Martinon-Martinez, JM; Gomez-Rial, J; Curras-Tuala, MJ; Pischedda, S; Barral-Arca, R; Justicia-Grande, A; Rivero-Calle, I
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Year:
2019
Doi:
https://doi.org/10.1016/j.vaccine.2019.04.086
IDENTIFICATION OF REGULATORY VARIANTS ASSOCIATED WITH GENETIC SUSCEPTIBILITY TO MENINGOCOCCAL DISEASE
Lisa Borghini, Eileen Png, Alexander Binder, Victoria J. Wright, Ellie Pinnock, Ronald de Groot, Jan Hazelzet, Marieke Emonts, Michiel Van der Flier, Luregn J. Schlapbach, Suzanne Anderson, Fatou Secka, Antonio Salas, Colin Fink, Enitan D. Carrol, Andrew J. Pollard, Lachlan J. Coin, Taco W. Kuijpers, Federico Martinon-Torres, Werner Zenz, Michael Levin, Martin L. Hibberd, Sonia Davila & EUCLIDS consortium
Journal:
Scientific Reports
Publicación independiente
Impact factor
3.998
Q1
Year:
2019
Doi:
https://doi.org/10.1038/s41598-019-43292-6
DEL GENOMA DE UN PATÓGENO A UNA VACUNA EFECTIVA: LA VACUNA DE CUATRO COMPONENTES FRENTE A LOS MENINGOCOCOS DEL SEROGRUPO B
Raquel Abad, Federico Martinón-Torres, María Elena Santolava, Angelika Banzhoff, Carmen González-Inchausti, María Gabriela Graña, Julio A. Vázquez
Journal:
Rev Esp Quimioter.
Publicación independiente
Impact factor
1.132
Q4
Year:
2019
Doi:
EPIDEMIOLOGICAL AND CLINICAL FEATURES OF KAWASAKI DISEASE IN SPAIN OVER 5 YEARS AND RISK FACTORS FOR ANEURYSM DEVELOPMENT. (2011-2016): KAWA-RACE STUDY GROUP
Elisa Fernandez-CookeI, Ana Barrios Tasco,, Judith Sa´nchez-Manubens, Jordi Antón, Carlos Daniel Grasa LozanoI, Javier Aracil Santos, Enrique Villalobos Pinto,, Daniel Clemente Garulo, Beatriz Mercader Rodríguez, Matilde Bustillo Alonso, Esmeralda Nuñez Cuadros, Maria Luisa Navarro Gómez, Sara Domínguez Rodríguez, Cristina Calvo, on behalf of the KAWA-RACE study group (Martinón-Torres, F; Rivero Calle, I, Justicia Grande, A)
Journal:
PLOS ONE,
Publicación independiente
Impact factor
2.740
Q2
Year:
2019
Doi:
OMIC TECHNOLOGIES AND VACCINE DEVELOPMENT: FROM THE IDENTIFICATION OF VULNERABLE INDIVIDUALS TO THE FORMULATION OF INVULNERABLE VACCI
Nicola Cotugno , Alessandra Ruggiero , Veronica Santilli, Emma Concetta Manno, Salvatore Rocca , Sonia Zicari, Donato Amodio , Manuela Colucci , Paolo Rossi, Ofer Levy, Federico Martinon-Torres , Andrew J. Pollard, and Paolo Palma
Journal:
Journal of Immunology Research
Publicación independiente
Impact factor
3.327
Q3
Year:
2019
Doi:
https://doi.org/10.1155/2019/8732191
FURTHER CONSIDERATIONS ON ROTAVIRUS VACCINATION AND SEIZURE-RELATED HOSPITALIZATION RATES
Jose Gómez-Rial, Sonia Sánchez-Batá, Irene Rivero-Calle, Jacobo Pardo-Seco, José María Martinón-Martínez, Antonio Salas, Federico Martinón-Torres,
Journal:
Infection and Drug Resistance
Publicación independiente
Impact factor
2.984
Q1
Year:
2019
Doi:
https://doi.org/10.2147/IDR.S208756
SAFETY AND IMMUNOGENICITY OF PNEUMOCOCCAL CONJUGATE VACCINES IN PRETERM INFANTS
Carolina López-Sanguos, Irene Rivero Calle, Carmen Rodriguez Tenreiro, Peter Francis Raguindin and Federico Martinón-Torres
Journal:
Expert Opin Drug Saf
Publicación independiente
Impact factor
3.383
Q2
Year:
2019
Doi:
https://doi.org/10.1080/14740338.2019.1597849
¿QUÉ HEMOS APRENDIDO SOBRE ROTAVIRUS EN ESPAÑA EN LOS ÚLTIMOS 10 AÑOS?
Javier Díez-Domingo, María Garcés-Sánchez, Francisco Giménez-Sánchez, Javier Colomina-Rodríguez, Federico Martinón-Torres
Journal:
An Pediatr (Barc)
Publicación independiente
Impact factor
1.313
Q3
Year:
2019
Doi:
https://doi.org/10.1016/j.anpedi.2019.01.024
LIFESTYLE AND COMORBID CONDITIONS AS RISK FACTORS FOR COMMUNITY-ACQUIRED PNEUMONIA IN OUTPATIENT ADULTS (NEUMO-ES-RISK project)
Irene Rivero-Calle, Miriam Cebey-López, Jacobo Pardo-Seco, José Yuste, Esther Redondo, Diego A Vargas, Enrique Mascarós,Jose Luis Díaz-Maroto, Manuel Linares-Rufo, Isabel Jimeno, Angel Gil, Jesus Molina, Daniel Ocaña,Federico Martinón-Torres, on behalf of NEUMOEXPERTOS group
Journal:
BMJ Open Respir Res
Publicación independiente
Impact factor
Year:
2019
Doi:
https://doi.org/10.1136/bmjresp-2018-000359
EFFICACY, IMMUNOGENICITY, AND SAFETY OF A QUADRIVALENT INACTIVATED INFLUENZA VACCINE IN CHILDREN AGED 6–35 MONTHS: A MULTI-SEASON RANDOMISED PLACEBO-CONTROLLED TRIAL IN THE NORTHERN AND SOUTHERN HEMISPHERES
Stephanie Pepin, Martin Dupuy, Charissa Fay Corazon Borja-Tabora, May Montellanoc, Lulu Bravo, Jaime Santos, Jo-Anne de Castro, Doris Maribel Rivera-Medina, Clare Cutland, Miguel Ariza, Javier Diez-Domingo, Celia Diaz Gonzalez, Federico Martinón-Torres, Efimia Papadopoulou-Alataki, Maria Theodoriadou, Marie Pierre Kazek-Duret, Sanjay Gurunathan, Iris De Bruijn, for the GQM05 Study Group
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Year:
2019
Doi:
https://doi.org/10.1016/j.vaccine.2018.11.074
ROTAVIRUS INFECTION BEYOND THE GUT
José Gómez-Rial, Sonia Sánchez-Batán, Irene Rivero-Calle, Jacobo Pardo-Seco, José María Martinón-Martínez, Antonio Salas, Federico Martinón-Torres
Journal:
Infection and Drug Resistance
Publicación independiente
Impact factor
2.984
Q2
Year:
2019
Doi:
https://doi.org/10.2147/IDR.S186404
IMPLEMENTING UNIVERSAL VARICELLA VACCINATION IN EUROPE: THE PATH FORWARD
Vana Spoulou, Sophie Alain, Giovanni Gabutti, Carlo Giaquinto, Johannes Liese, Federico Martinon-Torres and Timo Vesikari
Journal:
Pediatric Infect Dis J
Publicación independiente
Impact factor
2.126
Q2
Year:
2019
Doi:
https://doi.org/10.1097/INF.0000000000002233
Descripción de la gripe B en las epidemias estacionales de España
Raúl Ortiz de Lejarazu, Javier Diez Domingo, Ángel Gil de Miguel, Federico Martinón-Torres, Carlos Guzmán Quilo, José María Guillén, Blanca Piedrafita, Esther Redondo Marguello
Journal:
Rev, Esp. Quimioterapia
Publicación independiente
Impact factor
1.132
Q4
Year:
2018
Doi:
EVALUATION OF A HEXAVALENT-PENTAVALENT-HEXAVALENT INFANT PRIMARY VACCINATION SERIESFOLLOWED BY A PENTAVALENT BOOSTER VACCINE IN HEALTHY INFANTS AND TODDLERS
Federico Martinόn-Torres, Javier Diez-Domingo, Emmanuel Feroldi, Emilia Jordanov, Siham B’Chir, and Xavier Da Costa, Hospital Clinico Universitario de Santiago de Compostela, Spain;FISABIO-Public Health,Valencia, Spain; Sanofi Pasteur, France; Sanofi Pasteur, USA
Journal:
Pediatric Infect Dis J
Publicación independiente
Impact factor
2.126
Q2
Year:
2019
Doi:
https://doi.org/10.1097/INF.0000000000002231
ANAMNESTIC IMMUNE RESPONSE AND SAFETY OF AN INACTIVATED QUADRIVALENT INFLUENZA VACCINE IN PRIMED VERSUS VACCINE-NAÏVE CHILDREN
Claeys C, Chandrasekaran V, García-Sicilia J, Prymula R, Díez-Domingo J, Brzostek J, Marès-Bermúdez J, Martinón-Torres, Pollard AJ, Růžková R, Martinez AC, Ulied A, Valdivieso MM, Faust SN, Snape MD, Friel D, Ollinger T, Soni J, Schuind A, Li P, Innis BL, Jain VK.
Journal:
Pediatric Infect Dis J
Publicación independiente
Impact factor
2.126
Q2
Year:
2018
Doi:
https://doi.org/10.1097/INF.0000000000002217
ADULT COMMUNITY ACQUIRED PNEUMONIA VACCINATION: 2018 UPDATE OF THE POSITIONING OF THE PNEUMONIA PREVENTION EXPERT GROUP
Redondo E, Rivero-Calle I, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares M, Gil A, Molina J, Jimeno I, Ocaña D, Yuste JE, Martinón-Torres F, en nombre de Neumoexpertos en Prevención
Journal:
Semergen
Publicación independiente
Impact factor
Year:
2018
Doi:
https://doi.org/10.1016/j.semerg.2018.09.005
KAWASAKI DISEASE IN INFANTS 3 MONTHS OF AGE AND YOUNGER: A MULTICENTRE SPANISH STUDY
Grasa CD, Fernandez-Cooke E, Sánchzez-Manubens J, Antón J, Crespo D, García M, López A, Lirola Cruz MJ, Díaz-Delgado de la Peña r, Calvo C, Spanish network for the study of Kawasaki disease. KAWA-RACE (Martinón-Torres F)
Journal:
Ann Rheum Dis
Publicación independiente
Impact factor
16.102
Q1
Year:
2018
Doi:
PRIORITY NEEDS FOR CONDUCTING PANDEMIC-RELEVANT CLINICAL RESERACH WITH CHILDREN IN EUROPE: A CONSENSUS STUDY WITH PEDIATRIC CLINICIAN-RESEARCHERS.
Micaela Gal, Nina Gobat, Nicholas A. Francis, Kerenza Hood, Christopher C. Butler, Julia Bielicki, Pieter L. Fraaij, Mike Sharland, Jessica Jarvis, Annemarie M.C. van Rossum, Terho Heikkinen, Federico Martinon-Torres, Jethro Herberg, Angela Watkins, Steve A.R. Webb, Ronnie Moore, Prasanth Sukumar, and Alistair Nichol
Journal:
Pediatric Infect Dis J
Publicación independiente
Impact factor
2.126
Q2
Year:
2018
Doi:
https://doi.org/10.1097/INF.0000000000002204
DIAGNOSIS OF KAWASAKI DISEASE. USING A MINIMAL WHOLE-BLOOD GENE EXPRESSION SIGNATURE
Victoria J.Wright, Jethro A. Herberg,Myrsini Kaforou, Chisato Shimizu, Hariklia Eleftherohorinou, Hannah Shailes, Anouk M. Barendregt, Stephanie Menikou, Stuart Gormley, Maurice Berk, Long Truong Hoang, Adriana H. Tremoulet,John T. Kanegaye, Lachlan J. M. Coin, Mary P. Glodé, Martin Hibberd, TacoW. Kuijpers, Clive J. Hoggart, Jane C. Burns, Michael Levin, FRCPCH; for the Immunopathology of Respiratory, Inflammatory and Infectious Disease Study (IRIS) Consortium and the Pediatric; Emergency Medicine Kawasaki Disease Research Group (PEMKDRG)
Journal:
JAMA
Publicación independiente
Impact factor
45.540
Q1
Year:
2018
Doi:
CRITERIA HETEROGENEITY IN THE DIAGNOSIS OF ACUTE BRONCHIOLITIS IN SPAIN
Alfredo Cano-Garcinuño, Manuel Praena-Crespo, Isabel Mora-Gandarilla, Ignacio Carvajal-Urueña, María Teresa Callén-Blecua, Águeda García-Merino, Grupo de Expertos para el Diagnóstico de la Bronquiolitis (Martinon-Torres, F)
Journal:
An Ped
Publicación independiente
Impact factor
1.313
Q3
Year:
2018
Doi:
PAEDIATRIC RESEARCH IN SPAIN: CHALLENGES AND PRIORITIES.INVEST-AEP Platform
Cristina Calvo, Talía Sainz, Pilar Codoner-Franch, Begona Santiago,M. Luz García-García, César García Vera, M. Angeles Munoz-Fernandez,Antonio Pérez-Martínez, Irene Rivero, Cristina Fernandez Pérez,Asunción Mejías, Federico Martinón-Torres, Fernando Cabanas, Plataforma INVEST-AEP
Journal:
An Pediatr (Barc)
Publicación independiente
Impact factor
1.313
Q3
Year:
2018
Doi:
https://doi.org/10.1016/j.anpedi.2018.09.001
INMUNOGENICITY AND SAFETY OF MEASLES-MUMP-RUBELLA VACCINE AT TWO POTENCY ADMINISTERED TO HEALTHY CHILDREN AGED 12-15 MONTHS:A PHASE III, RANDOMIZED, NON-INFERIORITY TRIAL
Ahonen, Anitta; Berry, Andrea; Chatterjee,Archana; Clifford, Robert; Diaz Perez, Clemente; Diez-Domingo, Javier; Haney, Byron; Harrison, Christopher J;Kerdpanich, Angkool Phirangkul; Lee, Jimmy KF; Leonardi, Michael; Martinón-Torres, Federico; Miranda,Mariano; Perez Porcuna, Xavier Maria; Phongsamart, Wanatpreeya; Sharifah Huda, Engku Alwi; Toh, Teck-Hock; Twiggs, Jerry; Ulied Arminana, Angels; Varman, Meera; Zissman, Edward. GSK Vaccinesstaff: Caplanusi, Adrian; Carryn, Stephane; Henry, Ouzama; Povey, Michael.
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Year:
2018
Doi:
MENINGOCOCCAL B VACCINE IMMUNOGENICITY IN CHILDREN WITH DEFECTS IN COMPLEMENT AND SPLENIC FUNCTION
Federico Martinón-Torres, Ewa Bernatowska, Anna Shcherbina, Susanna Esposito, Leszek Szenborn, Magda Campins Marti, Stephen Hughes, Saul N. Faust, Luis I. Gonzalez-Granado, Ly-Mee Yu, Diego D’Agostino, Marco Calabresi, Daniela Toneatto, Matthew D. Snape
Journal:
Pediatrics
Publicación independiente
Impact factor
5.359
Q1
Year:
2018
Doi:
https://doi.org/10.1542/peds.2017-4250
MORTALITY AND MORBIDITY IN COMMUNITY-ACQUIRED SEPSIS IN EUROPEAN PEDIATRIC INTENSIVE CARE UNITS: A PROSPECTIVE COHORT STUDY FROM THE EUROPEAN CHILDHOOD LIFE-THREATENING INFECTIOUS DISEASE STUDY (EUCLIDS)
Navin P. Boeddha, Luregn J. Schlapbach, Gertjan J. Driessen, Jethro A. Herberg, Irene Rivero-Calle, Miriam Cebey-López, Daniela S. Klobassa, Ria Philipsen, Ronald de Groot, David P. Inwald, Simon Nadel, Stéphane Paulus, Eleanor Pinnock, Fatou Secka, Suzanne T. Anderson, Rachel S. Agbeko, Christoph Berger, Colin G. Fink, Enitan D. Carrol, Werner Zenz, Michael Levin, Michiel van der Flier, Federico Martinón-Torres, Jan A. Hazelzet, Marieke Emonts and on behalf of the EUCLIDS consortium
Journal:
Critical Care
Publicación independiente
Impact factor
6.407
Q1
Year:
2018
Doi:
https://doi.org/10.1186/s13054-018-2052-7
No results found.
REVIEW OF CLINICAL STUDIES COMPARING MENINGOCOCCAL SEROGROUP C IMMUNE RESPONSES INDUCED BY MENACWY-TT AND MONOVALENT SEROGROUP C VACCINES
Serra L, Knuf M, Martinón-Torres F, Yi K, Findlow J
Doi:
Hum Vaccin Immunother
Factor de impacto:
Q2
Doi:
VARIATION IN HOSPITAL ADMISSION IN FEBRILE CHILDREN EVALUATED AT THE EMERGENCY DEPARTMENT (ED) IN EUROPE: PERFORM, A MULTICENTRE PROSPECTIVE OBSERVATIONAL STUDY
Borensztajn DM, Hagedoorn NN, Rivero Calle I, Maconochie IK, von Both U, Carrol ED, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Lim E, Martinon-Torres F, Nieboer D, Nijman RG, Pokorn M, Strle F, Tsolia M, Vermont C, Yeung S, Zavadska D, Zenz W, Levin M, Moll HA; PERFORM consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union children to optimise Real-life Management across the European Union
Doi:
PLoS One
Factor de impacto:
Q2
Doi:
CHANGES IN EPIGENETIC PROFILES THROUGHOUT EARLY CHILDHOOD AND THEIR RELATIONSHIP TO THE RESPONSE TO PNEUMOCOCCAL VACCINATION
Pischedda S, O'Connor D, Fairfax BP, Salas A, Martinon-Torres F, Pollard AJ, Trück J.
Doi:
Clinical epigenetics
Factor de impacto:
Q1
Doi:
PHYLOGEOGRAPHY OF SARS-COV-2 PANDEMIC IN SPAIN: A STORY OF MULTIPLE INTRODUCTIONS, MICRO-GEOGRAPHIC STRATIFICATION, FOUNDER EFFECTS, AND SUPER-SPREADERS
Gómez-Carballa A, Bello X, Pardo-Seco J, Del Molino MLP, Martinón-Torres F, Salas A.
Doi:
Zoological Research
Factor de impacto:
Q1
Doi:
EXTRAORDINARY CLAIMS REQUIRE EXTRAORDINARY EVIDENCE IN ASSERTED MTDNA BIPARENTAL INHERITANCE
Antonio Salas, Sebastian Schönherr, Hans-Jürgen Bandelt, Alberto Gómez-Carballa, Hansi Weissensteiner (Federico Martinón Torres)
Doi:
Forensic Sci Int Genet
Factor de impacto:
Q1
Doi:
ROTAVIRUS AND AUTOIMMUNITY
Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F
Doi:
J Infect
Factor de impacto:
Q1
Doi:
GLOBAL MOLECULAR EPIDEMIOLOGY OF RESPIRATORY SYNCYTIAL VIRUS FROM THE 2017-2018 INFORM-RSV STUDY
Tabor, David E; Fernandes, Fiona; Langedijk, Annefleur C; Wilkins, Deidre; Lebbink, Robert Jan; Tovchigrechko, Andrey; Ruzin, Alexey; Kragten-Tabatabaie, Leyla; Jin, Hong; Esser, Mark T; Bont, Louis J; Abram, Michael E (Martinón-Torres, Federico)
Doi:
J. Clin. Microbiol
Factor de impacto:
Q1
Doi:
QUANTITATIVE MULTIPLEX PROFILING OF THE COMPLEMENT SYSTEM TO DIAGNOSE COMPLEMENT‐MEDIATED DISEASES
Esther Willems Laura Lorés‐Motta Andrea Zanichelli Chiara Suffritti Michiel van der Flier Renate G van der Molen Jeroen D Langereis Joris van Drongelen Lambert P van den Heuvel Elena Volokhina Nicole CAJ van de Kar Jenneke Keizer‐Garritsen Michael Levin Jethro A Herberg Federico Martinon‐Torres Hans JTC Wessels Anita de Breuk Sascha Fauser Carel B Hoyng Anneke I den Hollander Ronald de Groot Alain J van Gool Jolein Gloerich Marien I de Jonge
Doi:
Clinical & Translational Immunology
Factor de impacto:
Q2
Doi:
DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR INVASIVE BACTERIAL INFECTIONS IN FEBRILE CHILDREN AT EUROPEAN EMERGENCY DEPARTMENTS: MOFICHE, A PROSPECTIVE OBSERVATIONAL STUDY
Nienke N Hagedoorn, Dorine Borensztajn, Ruud Gerard Nijman, Daan Nieboer, Jethro Adam Herberg, Anda Balode, Ulrich von Both, Enitan Carrol, Irini Eleftheriou, Marieke Emonts, Michiel van der Flier, Ronald de Groot, Benno Kohlmaier, Emma Lim, Ian Maconochie, Federico Martinón-Torres, Marko Pokorn, Franc Strle, Maria Tsolia, Dace Zavadska, Werner Zenz, Michael Levin, Clementien Vermont, Henriette A Moll
Doi:
Hagedoorn NN,
Factor de impacto:
Q1
Doi:
PREVENTION OF NEW RESPIRATORY EPISODES IN CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS: AN EXPERT CONSENSUS STATEMENT
Susanna Esposito, Marcus Herbert Jones, Wojciech Feleszko, José A. Ortega Martell, Oana Falup-Pecurariu, Natalia Geppe , Federico Martinón-Torres, Kun-Ling Shen, Michael Roth and Nicola Principi
Doi:
Microorganisms
Factor de impacto:
Q2
Doi:
ROUTINE INFANT VACCINATION OF PNEUMOCOCCAL CONJUGATE VACCINES HAS DECREASED PNEUMONIA ACROSS ALL AGE GROUPS IN NORTHERN SPAIN
I. Rivero-Calle, J. Pardo Seco, P. F. Raguindin, F. Alvez, J. Gómez-Rial, A. Salas, J. Martinón Sanchez and F. Martinón-Torres
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
QUADRIVALENT INFLUENZA VACCINE PREVENTS ILLNESS AND REDUCES HEALTHCARE UTILIZATION ACROSS DIVERSE GEOGRAPHIC REGIONS DURING FIVE INFLUENZA SEASONS. A RANDOMIZED CLINICAL TRIAL
Ghassan Dbaibo, Arshad Amanullah, Carine Claeys, Allen Izu, Varsha K. Jain, Pope Kosalaraksa, Luis Rivera, Jyoti Soni, Emad Yanni, Khalequ Zaman, Beatriz Acosta, Miguel Ariza, Maria L. Arroba Basanta, Ashish Bavdekar, Alfonso Carmona, Luis Cousin, Jasur Danier, Alfonso Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, Jose Garcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, Mustafa Hacimustafaoglu, Stephen M. Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, Roman Prymula, Thanyawee Puthanakit, Renata Ruzkova, Iwona Sadowska-Krawczenko Henryk Szymanski, Angels Ulied, Wayne Woo, Anne Schuind and Bruce L. Innis for the Flu4VEC Study Group
Pediatr Infect Dis J
Factor de impacto:
Doi:
Links
Department of pediatricsGenCovidNanostringNextSeq
Legal noticePrivacy policy
Genvip 2023® – All rights reserved